Global Pharmaceutical Amino Acids Market Report, History and Forecast 2017-2028
Market Analysis and Insights: Global Pharmaceutical Amino Acids Market
The global Pharmaceutical Amino Acids market was valued at US$ 1,326.13 million in 2021 and will reach US$ 1,569.19 million by the end of 2028, growing at a CAGR of 2.5% during 2022-2028.
In the industry, the key players in the global Pharmaceutical Amino Acids market are like Ajinomoto, Evonik, Kyowa Hakko, AMINO, Meihua Holding Group, Tianjin Tianyao, Jingjing, Wuxi Jinghai, Jiahe Biotech, Hubei Bafeng, Grand Hoyo, Yichang Sanxia Proudin and Shine Star, etc. Ajinomoto shipments most in 2021 and recent years, while Evonik and Kyowa Hakko ranked 2 and 3.The gap of market share is keep on enlarged due to different strategy. The market concentration ratio in the past three years. The top five manufacturers held 67.44% of the market, in terms of Pharmaceutical Amino Acids revenue in 2021.
Asia has the largest global export quantity and manufacturers in Pharmaceutical Amino Acids market, global leading companies all have production bases in China.
Demand is growing worldwide in the market for amino acids for pharmaceuticals, and steady growth is forecast to continue. The demand for high-quality amino acids centering on the biopharmaceuticals business in particular is growing. Also, since development is proceeding on antibody drugs and biosimilars (follow-on biologics), strong growth is expected to continue in the culture media market for biopharmaceuticals. However, we must keep a close watch on factors such as distribution delays and the skyrocketing costs of raw materials and fuel stemming from the Ukraine situation.
On the basis of amino acids type, the Pharmaceutical Amino Acids market has been segmented into Glycine, L-Threonine, L-Alanine, L-Leucine, L-Cysteine, L-Arginine, L-Valine, L-Isoleucine and Others. Glycine is the largest type, Glycine accounts for about 31.68% of the total sales in 2021, with a sales volume of 16,650 metric tons. The L-Alanine and L-Isoleucine segment of Pharmaceutical Amino Acids is projected to register the highest CAGR during the forecast period.
Active Pharmaceuticals Ingredients (APIs) is estimated to be the largest application of Pharmaceutical Amino Acids. Cell Culture Media Ingredients are expected to show the fastest growth rates in the Pharmaceutical Amino Acids market in the coming years.
Affected by the COVID-19, the operating rate of small manufacturer has declined, and the market share of large manufacturer has increased rapidly. It is expected that major manufacturer will continue to expand production capacity in the next five years.
The market growth rate (by volume) is expected to exceed 6.99% in 2022.
On the basis of region, the Pharmaceutical Amino Acids market has been segmented into Asia, Europe, USMCA, Middle East, CIS, Central & South America, Africa, Oceania. USMCA is projected to be the largest market during the forecast period. The demand for Pharmaceutical Amino Acids is high in developing economies such as China and India. High growth and innovation, along with industry consolidations, are expected to drive the market in the region.
In terms of production side, this report researches the Pharmaceutical Amino Acids capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2017 to 2022, and forecast to 2028.
The production capacity in this report is mainly based on the nameplate capacity, and the manufacturer's capacity data includes the part of the joint venture.
It should be pointed out that the revenue market size described in this report refers to the output value calculated according to the market price of Pharmaceutical Amino Acids. Most Pharmaceutical Amino Acids production enterprises have downstream derivatives manufacturing business, and the Pharmaceutical Amino Acids traded between enterprises are usually quoted based on the market price, plus processing fees.
In this report, MT refers to Metric Tones.
In terms of sales side, this report focuses on the sales of Pharmaceutical Amino Acids by regions (countries), company, by Progress and by Application. from 2017 to 2022 and forecast to 2028.
The global Pharmaceutical Amino Acids market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Progress segment of the global Pharmaceutical Amino Acids market. These figures have been provided in terms of both revenue and volume for the period 2017-2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
By Company
─ Ajinomoto
─ Evonik
─ Kyowa Hakko
─ AMINO
─ Meihua Holding Group
─ Tianjin Tianyao
─ Jingjing
─ Wuxi Jinghai
─ Jiahe Biotech
─ Hubei Bafeng
─ Grand Hoyo
─ Yichang Sanxia Proudin
─ Shine Star
Segment by Type
─ Glycine
─ L-Threonine
─ L-Alanine
─ L-Leucine
─ L-Cysteine
─ L-Arginine
─ L-Valine
─ L-Isoleucine
─ Others
Segment by Application
─ Active Pharmaceuticals Ingredients (APIs)
─ Pharmaceutical Intermediates
─ Cell Culture Media Ingredients
─ Pharmaceutical Excipients
─ Medical Food
─ Others
Sales by Region
─ Asia Pacific
─ Europe
─ USMCA
─ Middle East and Africa
─ CIS
─ Central & South America
─ China
─ Japan
─ South Korea
─ India
─ Taiwan China
─ Indonesia
─ Thailand
─ Germany
─ France
─ Italy
─ United Kingdom
─ Netherlands
─ Spain
─ Switzerland
─ United States
─ Mexico
─ Canada
─ Saudi Arabia
─ Iran
─ Brazil
─ Argentina
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook